- Monogram Technologies (MGRM, Financial) schedules Q1 2025 earnings call for May 14, 2025.
- Discussion topics include recent FDA 510(k) Clearance and clinical trials approval in India.
- CEO Ben Sexson and CFO Noel Knape to host the event.
Monogram Technologies, Inc. (NASDAQ:MGRM), a company at the forefront of AI-driven robotics in orthopedic surgery, has announced its first quarter 2025 earnings conference call. The event is slated for Wednesday, May 14, 2025, at 4:30 p.m. Eastern Time, where CEO Ben Sexson and CFO Noel Knape will present the financial results for the quarter that ended March 31, 2025.
During the call, the team will delve into key regulatory updates, notably the FDA 510(k) clearance for their Monogram mBôs TKA System, an innovative solution aimed at improving surgical precision. Furthermore, the discussion will extend to cover the company's recent approval to initiate clinical trials in India, highlighting critical milestones in Monogram's operational journey.
A detailed press release shedding light on these developments will be released prior to the call. Interested parties can access a presentation on the investor relations section of Monogram's website.
The conference call is set to be broadcast live, with options available for replay access through the company's investor relationships page. The registration link for the live webcast is available at this link.
Monogram Technologies is dedicated to leveraging AI and next-generation robotics technology to revolutionize orthopedic implants, aiming to provide patient-optimized solutions through their mBôs precision robotic surgical system.
